Pancreatic Cancer Research

ResearcherHyogo Medical UniversityActive in the last 2 years

Hirayuki Enomoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1334-1149; OpenAlex author ID A5027049654. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Possible Relevance of Hepatoma-derived Growth Factor and Alkylglycerone Phosphate Synthase to Pancreatic Cancer Progression. Co-author DOI 10.21873/invivo.14485↗
  2. Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy. Co-author DOI 10.7150/jca.38861↗
  3. Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. Co-author DOI 10.1136/bmjgast-2017-000194↗
  4. Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial. Co-author DOI 10.1136/bmjgast-2017-000196↗
  5. Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy. Co-author DOI 10.3892/ol.2017.6952↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noriko Kawamura Ishii · 4 shared papers, 2017–2020 · strength 0.30
  2. Shuhei Nishiguchi · 4 shared papers, 2017–2020 · strength 0.30
  3. Takashi Nishimura · 4 shared papers, 2017–2020 · strength 0.30
  4. Shinichiro Shinzaki · 1 shared paper, 2026 · strength 0.28
  5. Kazunori Yoh · 3 shared papers, 2017–2018 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.